Introduction {#tca13527-sec-0006}
============

Lung cancer is one of the leading cancers both in morbidity and mortality worldwide,[^1^](#tca13527-bib-0001){ref-type="ref"} and the overwhelming subtype of lung cancers representing 85% of cases is non‐small cell lung cancer (NSCLC).[^2^](#tca13527-bib-0002){ref-type="ref"} Lung cancers in particular have been a major public health problem in China.[^3^](#tca13527-bib-0003){ref-type="ref"} In terms of treatment strategy of lung cancers, surgical resection, platinum‐based dual chemotherapy and target therapy are the first‐line approaches.[^4^](#tca13527-bib-0004){ref-type="ref"} However, the long time overall survival of patients with NSCLC is only about 18%,[^5^](#tca13527-bib-0005){ref-type="ref"} and is still closely related to the stage. In addition, there are still many clinical challenges in NSCLC, including early diagnosis.[^6^](#tca13527-bib-0006){ref-type="ref"} Cisplatin (DDP), the first metal‐based anticancer drug, is widely used in solid cancers including lung cancer[^7^](#tca13527-bib-0007){ref-type="ref"}; however, DDP resistance has been reported to occur in approximately 63% of NSCLC patients.[^8^](#tca13527-bib-0008){ref-type="ref"}

Circular RNAs (circRNAs) are a class of endogenous, covalently closed RNAs produced from 'back‐splicing' of primary transcripts.[^9^](#tca13527-bib-0009){ref-type="ref"}, [^10^](#tca13527-bib-0010){ref-type="ref"} Compared with linear RNAs, circRNAs are more stable in vivo over an extended period.[^11^](#tca13527-bib-0011){ref-type="ref"} CircRNAs are deemed to be diagnostic and prognostic biomarkers in lung cancers,[^3^](#tca13527-bib-0003){ref-type="ref"} including NSCLC.[^12^](#tca13527-bib-0012){ref-type="ref"} Functionally, progress in research on the role of circRNAs has also been highlighted in lung cancers.[^13^](#tca13527-bib-0013){ref-type="ref"}, [^14^](#tca13527-bib-0014){ref-type="ref"} In particular, circRNAs are able to modulate chemoresistance in lung cancers.[^15^](#tca13527-bib-0015){ref-type="ref"}

It has been well documented that circRNAs can serve as competitive endogenous RNAs (ceRNAs) to inhibit cellular function,[^16^](#tca13527-bib-0016){ref-type="ref"} and ceRNAs interplay has evolved in the pathogenesis of human cancers including lung cancer.[^17^](#tca13527-bib-0017){ref-type="ref"} MicroRNAs (miRNAs) are a class of small, linear noncoding RNAs. Recently, miRNA (miR)‐519d‐3p was found to be downregulated in 97.1% of tissues of NSCLC patients.[^18^](#tca13527-bib-0018){ref-type="ref"} However, the role of miR‐519d‐3p is still unclear in NSCLC cells.

The hsa_circ_0007385 (circ_0007385) is derived from host gene MEMO1, and has been declared to be upregulated in NSCLC tissues and cells.[^19^](#tca13527-bib-0019){ref-type="ref"} In this study, we intended to determine the role of circ_0007385 in malignant behaviors and DDP resistance of NSCLC cells. Furthermore, the cross‐talk among circ_0007385, miR‐519d‐3p and high‐mobility group box 1 (HMGB1) was revealed. HMGB1 is a potential biomarker and therapeutic target for multiple cancers,[^20^](#tca13527-bib-0020){ref-type="ref"} including lung cancer.[^21^](#tca13527-bib-0021){ref-type="ref"}, [^22^](#tca13527-bib-0022){ref-type="ref"}

Methods {#tca13527-sec-0007}
=======

Tissue sample collection {#tca13527-sec-0008}
------------------------

A cohort of 75 NSCLC patients were recruited at Gansu Wuwei Tumor Hospital, and the fresh tumor tissues and adjacent normal tissues (≥5 cm from tumor margin) were collected during the radical operation after written consent was received from each patient. These patients experienced no systemic chemotherapy or radiotherapy prior to surgery, and the tumor nodes metastasis (TNM) stage was classified according to the American Joint Committee on Cancer lung cancer staging system (eighth edition). The tissue samples were snap‐frozen in liquid nitrogen. This study was approved by the Ethics Committee of Gansu Wuwei Tumor Hospital.

Cell culture {#tca13527-sec-0009}
------------

Human NSCLC cell lines including A549 (CRM‐CCL‐185), HCC827 (CRL‐2868), H1975 (CRL‐5908), and H2342 (CRL‐5941) were from the American Type Culture Collection (Manassas, VA, USA), and a normal bronchial epithelial cell line 16HBE (SCC150) was from Millipore (Billerica, MA, USA). The NSCLC cells were maintained in RPMI 1640 (Hyclone, Logan, UT, USA), and 16HBE cells were in DMEM (HyClone). All the cells were incubated in 10% fetal bovine serum (FBS; HyClone) at 37°C with 5% CO~2~.

Real‐time quantitative PCR (RT‐qPCR) {#tca13527-sec-0010}
------------------------------------

Total RNA in tissues and cell lines was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) in line with the instructions, and an aliquot of RNA sample (1 μg) was used to synthesize cDNA using RevertAid First‐Strand cDNA Synthesis kit (Thermo Fisher Scientific, Foster City, CA, USA). The RT‐qPCR was performed using cDNA, primers and SYBR Green Mix (Thermo Fisher Scientific) on Applied Biosystems 7900 (Thermo Fisher Scientific). The primers were target circ_0007385 (5′‐CGTGACCCAGAAGTGCGTTCACA‐3′, 5′‐TGGGGGTGTATCAGTCTTTGGTT‐3′),[^18^](#tca13527-bib-0018){ref-type="ref"} miR‐519d‐3p (5′‐TCCGAGTGAGATTTCCCTC‐3′ and 5′‐GTGCAGGGTCCGAGGT‐3′), HMGB1 (5′‐CTTCTTGAGGGGAAGCTAGT‐3′ and 5′‐TTTTGGATGTTCAGTTATGG‐3′), glyceraldehyde‐phosphate dehydrogenase (GAPDH; 5′‐GTGGACATCCGCAAAGAC‐3′ and 5′‐AAAGGGTGTAACGCAACTA‐3′), and U6 (5′‐TCCGATCGTGAAGCGTTC‐3′ and 5′‐GTGCAGGGTCCGAGGT‐3′). GAPDH was used as an endogenous control for circ_0007385 and HMGB1, and U6 was for miR‐519d‐3p. The relative expression level was calculated using the 2(‐Delta Delta C(T)) method,[^23^](#tca13527-bib-0023){ref-type="ref"} and every reaction group was repeated in at least four wells.

Cell transfection {#tca13527-sec-0011}
-----------------

The short hairpin RNA (shRNA) targeting circ_0007385 (sh‐circ; 5′‐AAUAGAACACUUACUACUAAUCUGdTdT‐3′ and 3′‐dTdTAUUCCCUAGCCCUUCGAGUGTT‐5′),[^18^](#tca13527-bib-0018){ref-type="ref"} miR‐519d‐3p mimic (5′‐CAAAGUGCCUCCCUUUAGAGUG‐3′), and miR‐519d‐3p inhibitor (anti‐miR‐519d‐3p; 5′‐CACUCUAAAGGGAGGCACUUUG‐3′) were chemically synthesized by Songon Biotech (Shanghai, China), as well as the negative controls. The overexpression vector of HMGB1 was constructed using pEEGFP‐C1 (Clontech, Mountain View, CA, USA). For transfection, A549 and H1975 cells were passaged in a six‐well plate at a density of 2 × 10^5^ cells/well, and vectors (2 μg) and small RNAs (40 nM) were transfected into cells using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's instruction. After transfection for 48 hours, the transfected cells were collected for RT‐qPCR and western blotting analysis.

Cell counting kit (CCK)‐8 for cell viability and half maximal inhibitory concentration (IC50) of DDP {#tca13527-sec-0012}
----------------------------------------------------------------------------------------------------

Transfected A549 and H1975 cells were transferred in 96‐well plates at a density of 5 × 10^3^ cells/well. Every transfection group was repeated in six wells. The transfected cells were incubated in normal cell culture condition for 24, 48 and 72 hours. For IC50 analysis, after transfection for 48 hours, A549 and H1975 cells were exposed to 2.5, 5, 10, 20, 40, and 80 μM of DDP (Sigma‐Aldrich, St. Louis, MO, USA) for another 24 hours. At indicated times, 10 μL of CCK‐8 solution (Dojindo, Tokyo, Japan) was added in each well. With another 2 hours incubation in the dark, the optical density value at 450 nm (OD 450 nm value) was measured with a microplate reader (Bio‐Rad, Hercules, CA, USA). With OD450 values, DDP‐induced inhibition rate (%) of cell viability was calculated.

Transwell assays for cell migration and invasion {#tca13527-sec-0013}
------------------------------------------------

After 48 hours transfection, A549 and H1975 cells were collected, and 5 × 10^5^ cells were resuspended in 200 μL of serum‐free RPMI 1640. For migration assay, transwell chamber (Costar, Shanghai, China) was placed in a 24‐well plate, and cell suspension was loaded in the upper chamber. The lower chamber was filled with 400 μL of RPMI 1640 containing 20% FBS (Hyclone). The transwell system was incubated in normal cell culture condition for another 48 hours. For invasion assay, the chamber was precoated with Matrigel (BD Biosciences, Mountain View, CA, USA) membrane by incubating with Matrigel: RPMI 160 (1: 9) at room temperature for overnight. Then, the migrated cells or invaded cells on the lower surface were fixed with 4% paraformaldehyde for 15 minutes, and dyed with 0.25% crystal violet for 20 minutes at room temperature. Finally, the migratory and invasive cells were observed under microscope, and five randomly selected fields were captured at magnification of 100×.

Western blotting {#tca13527-sec-0014}
----------------

Total protein in tissues and cell lines was extracted in RIPA reagent (Beyotime, Shanghai, China) supplemented with protease inhibitor PMSF (Sigma‐Aldrich). Then, an aliquot of protein sample (20 μg) was separated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis, and then transferred onto polyvinylidene fluoride (PVDF; Millipore) membrane. After blocking in 5% skin milk, the membranes were incubated in primary antibodies from Proteintech (Deansgate, Manchester, UK) including anti‐HMGB1 (10829‐1‐AP, 1: 2000), antiproliferating cell nuclear antigen (PCNA; 10 205‐2‐AP, 1: 10000), anti‐E‐cadherin (E‐cad; 20 874‐1‐AP, 1: 50000), anti‐N‐cadherin (N‐cad; 22 018‐1‐AP, 1: 10000), and anti‐GAPDH (10494‐1‐AP, 1: 40000) at 4°C for overnight, and in secondary antibody anti‐rabbit IgG‐HRP (sc‐2357, 1: 5000) from Santa Cruz (Shanghai, China) at room temperature for 2 hours. The protein blots were developed using ECL reagent (Millipore), and captured by Chemiluminescence (Thermo Fisher Scientific). GAPDH was the internal control.

Flow cytometry (FCM) for apoptosis rate and caspase‐3 activity {#tca13527-sec-0015}
--------------------------------------------------------------

After transfection for 48 hours, A549 and H1975 cells in six‐well plate were exposed to 5 μM of DDP (Sigma‐Aldrich) for another 24 hours. Cell apoptosis was measured by FCM using Annexin V fluorescein isothiocyanate (FITC) apoptosis detection kit (Beyotime) and CaspGLOW fluorescein active caspase‐3 staining kit (Thermo Fisher Scientific) following the manufacturer's instructions. Apoptosis rate (%) was measured using a FACScan flow cytometer (BD Biosciences) equipped with CellQuest software (BD Biosciences). Caspase‐3 fluorescence intensity was analyzed by FCM, and relative caspase‐3 activity was calculated comparing to control cells.

Dual‐luciferase reporter assay {#tca13527-sec-0016}
------------------------------

The full length of circ_0007385 and 3′‐untranslated region of HMGB1 (HMGB1 3\'UTR) were inserted into pGL4 luciferase reporter vector (Promega, Fitchburg, WI, USA), thus establishing the wild‐type of circ_0007385 vectors (circ_0007385 WT) and HMGB1 3\'UTR vectors (HMGB1 3\'UTR WT). Then, the putative binding sites of miR‐519d‐3p in circ_0007385 and HMGB1 3\'UTR were mutated, and their mutated‐type (MUT) vectors (circ_0007385 MUT and HMGB1 3\'UTR MUT) were similarly constructed. A549 and H1975 cells were passaged in a 24‐well plate at a density of 5 × 10^4^ cells/well, and cotransfected with miR‐519d‐3p/NC mimic (10 μM) and either circ_0007385 WT/MUT (300 ng) or HMGB1 3\'UTR WT/MUT (300 ng) using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's instruction. Post transfection for 48 hours, the Firefly and Renilla luciferase activities were measured on dual luciferase reporter (DLR) system (Promega). Relative luciferase activity was the ratio of Firefly/Renilla luciferase activity, normalized to control cells.

Xenograft experiment {#tca13527-sec-0017}
--------------------

A total of 10 BALB/c nude mice (5--7‐week‐old, male) were purchased from Vital River Laboratory Animal Technology (Beijing, China). The mice were divided into sh‐circ group (*n* = 5) and sh‐NC group (*n* = 5), and then were subcutaneously injected with A549 cells (5 × 10^6^ cells) transfected with sh‐circ or sh‐NC into the right flanks. The xenograft mice were further raised for days, and the dimension of neoplasms was measured every seven days after transplantation. The tumor volume (mm^3^) was calculated using the formula: (length×width^2^)/2. The tumor weight (mg) was measured on electronic balance on the day 28 after euthanasia of mice. This animal experiment was approved by the Ethics Committee of the Gansu Wuwei Tumor Hospital, and all procedures were strictly conformed to the Guide for the Care and Use of Laboratory Animals from NIH.

Statistical analysis {#tca13527-sec-0018}
--------------------

All data were analyzed using GraphPad software 7.0 (GraphPad, San Diego, CA, USA). The *P*‐values were obtained using Student\'s *t*‐test, one‐way analysis of variance, and Pearson correlation coefficient test. *P* \< 0.001 was considered statistically significant, and labeled using \*\*.

Results {#tca13527-sec-0019}
=======

Circ_0007385 was upregulated in NSCLC tumor tissues and cells {#tca13527-sec-0020}
-------------------------------------------------------------

A group of 75 primary NSCLC tumor tissues were collected, as well as the paired adjacent normal tissues. The expression of circ_0007385 in tissues was detected using RT‐qPCR, and circ_0007385 level was higher in NSCLC tumors (Fig [1a](#tca13527-fig-0001){ref-type="fig"}), and was even higher in advanced tumors (III + IV stages; n = 43) (Fig [1b](#tca13527-fig-0001){ref-type="fig"}). Moreover, the five‐year overall survival of these NSCLC patients was about 18% in the circ_0007385 high expression group (≥mean, *n* = 39; Fig [1c](#tca13527-fig-0001){ref-type="fig"}), and about 39% in the circ_0007385 low expression group (\<mean, *n* = 36; Fig [1c](#tca13527-fig-0001){ref-type="fig"}). Expression of circ_0007385 in human NSCLC cell lines was also detected, and RT‐qPCR data showed an overall upregulation of circ_0007385 in A549, HCC827, H1975, and H2342 cells versus 16HBE (Fig [1d](#tca13527-fig-0001){ref-type="fig"}). These results indicated that circ_0007385 was deregulated in NSCLC tissues and cells, suggesting a potential biological role of circ_0007385 in malignant progression of NSCLC cells.

![The expression of hsa_circ_0007385 (circ_0007385) in non‐small cell lung cancer (NSCLC) tissues and cells. (**a** and **b**) RT‐qPCR measured relative expression of circ_0007385 in (**a**) NSCLC tumor tissues (Tumor, *n* = 75) and adjacent normal tissues (Normal, *n* = 75) and (**b**) low grade (I + II; *n* = 32) and high grade (III + IV*; n* = 43) of tumors. (**c**) Kaplan‐Meier survival curve showed the overall survival (%) of NSCLC patients with circ_0007385 high expression (≥mean, *n* = 39) or low expression (\<mean, *n* = 36). (**d**) RT‐qPCR measured circ_0007385 expression level in human NSCLC cell lines (A549, HCC827, H1975, and H2342), and one human bronchial epithelial cell line (16HBE). \*\**P* \< 0.01.](TCA-11-2196-g001){#tca13527-fig-0001}

Interfering circ_0007385 depressed NSCLC cell proliferation, migration and invasion in vitro {#tca13527-sec-0021}
--------------------------------------------------------------------------------------------

The expression of circ_0007385 was exogenously silenced using shRNA transfection, and RT‐qPCR analysis confirmed transfection efficiency. As shown in Fig [2a](#tca13527-fig-0002){ref-type="fig"}, circ_0007385 level was significantly lowered in A549 and H1975 cells with sh‐circ transfection. Then, the role of circ_0007385 silence was further investigated in A549 and H1975 cells. CCK‐8 assay displayed a decrease of cell viability in circ_0007385‐downregulated cells, compared to sh‐NC‐transfected cells (Fig [2b and c](#tca13527-fig-0002){ref-type="fig"}). Transwell assays measured that migratory cells and invasive cells were declined by sh‐circ introduction (Fig [2d and e](#tca13527-fig-0002){ref-type="fig"}). In addition, western blotting result showed an increase of E‐cad, and a decrease of PCNA and N‐cad in response to sh‐circ transfection in A549 and H1975 cells (Fig [2f](#tca13527-fig-0002){ref-type="fig"}). These data together demonstrated that circ_0007385 knockdown could depress cell proliferation, migration and invasion in NSCLC cells in vitro.

![The effect of circ_0007385 knockdown on NSCLC cell proliferation, migration and invasion in vitro. (**a**--**f**) A549 and H1975 cells were transfected with shRNA targeting circ_0007385 (sh‐circ) or the negative control sh‐NC for 48 hours. (**a**) RT‐qPCR confirmed the circ_0007385 level () sh‐NC, () sh‐circ. (**b** and **c**) CCK‐8 assessed optical density value at 450 nm (OD450 nm value) at 24, 48 and 72 hours () sh‐NC, () sh‐circ; (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ. (**d** and **e**) Transwell assays determined the number of migratory and invasive cells () sh‐NC, () sh‐circ; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ. (**f**) Western blotting detected protein expression of the proliferating cell nuclear antigen (PCNA), E‐cadherin (E‐cad) and N‐cadherin (N‐cad) (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ. \*\**P* \< 0.01.](TCA-11-2196-g002){#tca13527-fig-0002}

Silencing circ_0007385 inhibited DDP resistance of NSCLC cells in vitro {#tca13527-sec-0022}
-----------------------------------------------------------------------

Next, the role of circ_0007385 in DDP resistance of NSCLC cells was explored. With treatment of 2.5, 5, 10, 20, 40, and 80 μM of DDP, cell viability inhibition was observed in transfected A549 and H1975 cells; moreover, IC50 of DDP was reduced by sh‐circ transfection from 10.39 to 5.92 μM in A549 cells, and from 13.69 to 7.77 μM in H1975 cells (Fig [3a and b](#tca13527-fig-0003){ref-type="fig"}). Moreover, circ_0007385 deletion enhanced apoptosis rate (Fig [3c and d](#tca13527-fig-0003){ref-type="fig"}) and caspase‐3 activity (Fig [3e and f](#tca13527-fig-0003){ref-type="fig"}) in A549 and H1975 cells with 5 μM of DDP treatment. These data suggested a suppression of circ_0007385 knockdown on DDP resistance in NSCLC cells in vitro.

![The effect of circ_0007385 knockdown on cisplatin (DDP) sensitivity of NSCLC cells in vitro. (**a**--**f**) A549 and H1975 cells were transfected with sh‐circ or sh‐NC, and then treated with DDP for 48 hours. (**a** and **b**) CCK‐8 measured the inhibition rate (%) of cell viability after treatment of 0, 2.5, 5, 10, 20, 40, and 80 μM of DDP (![](TCA-11-2196-g011.jpg "image")) sh‐NC IC50 = 10.39, (![](TCA-11-2196-g012.jpg "image")) sh‐circ IC50 = 5.92; (![](TCA-11-2196-g011.jpg "image")) sh‐NC IC50 = 13.69, (![](TCA-11-2196-g012.jpg "image")) sh‐circ IC50 = 7.77. IC50, half maximal inhibitory concentration. (**c** and **d**) Flow cytometry (FCM) and Annexin V fluorescein isothiocyanate (FITC) apoptosis detection kit examined apoptosis rate (%) after treatment of 10 μM of DDP. (**e** and **f**) FCM and fluorescein active caspase‐3 staining kit examined relative caspase‐3 activity after treatment of 10 μM of DDP. \*\**P* \< 0.01.](TCA-11-2196-g003){#tca13527-fig-0003}

Circ_0007385 negatively regulated miR‐519d‐3p via target binding {#tca13527-sec-0023}
----------------------------------------------------------------

By searching the StarBase database, we took miR‐519d‐3p as a candidate for circ_0007385, and the potential binding site between the circ_0007385 WT and miR‐519d‐3p is shown in Fig [4a](#tca13527-fig-0004){ref-type="fig"}. Exogenous transfection of miR‐519d‐3p mimic obviously attenuated luciferase activity of pGL4 report vector carrying circ_0007385 WT in A549 and H1975 cells (Fig [4b and c](#tca13527-fig-0004){ref-type="fig"}). Additionally, we confirmed a downregulation of miR‐519d‐3p in NSCLC tumor tissues (*n* = 75; Fig [4d](#tca13527-fig-0004){ref-type="fig"}), and its expression was negatively correlated with circ_0007385 (*r* = 0.6273, *P* \< 0.001; Fig [4e](#tca13527-fig-0004){ref-type="fig"}). In addition, expression of miR‐519d‐3p was lower in A549 and H1975 cells than that in 16HBE cells (Fig [4f](#tca13527-fig-0004){ref-type="fig"}), and was upregulated in A549 and H1975 cells with circ_0007385 knockdown (Fig [4g](#tca13527-fig-0004){ref-type="fig"}). These results suggested that circ_0007385 could serve as a ceRNA for miR‐519d‐3p via target binding in NSCLC.

![The target relationship between circ_0007385 and miRNA (miR)‐519d‐3p. (**a**) The StarBase algorithms showed the complementary binding sequence of miR‐519d‐3p on the wild‐type of circ_0007385 (circ_0007385 WT). The mutant type of circ_0007385 (circ_0007385 MUT) was constructed. (**b** and **c**) Dual‐luciferase reporter assay evaluated relative luciferase activity of circ_0007385 WT/MUT in A549 and H1975 cells transfected with miR‐519d‐3p mimic (miR‐519d‐3p) or miR‐NC mimic (miR‐NC) (![](TCA-11-2196-g009.jpg "image")) miR‐NC, (![](TCA-11-2196-g010.jpg "image")) miR‐519d‐3p; () miR‐NC, () miR‐519d‐3p. (**d**) RT‐qPCR detected relative expression of miR‐519d‐3p in tissues in the Normal (*n* = 75) and Tumor (*n* = 75) groups. (e) Pearson correlation coefficient (*r*) analysis determined the correlation between circ_0007385 and miR‐519d‐3p expression in NSCLC tumors (*n* = 75). (**f** and **g**) RT‐qPCR detected miR‐519d‐3p level in (**f**) 16HBE, A549 and H1975 cells, and (**g**) A549 and H1975 cells transfected with sh‐circ or sh‐NC (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ. \*\**P* \< 0.01.](TCA-11-2196-g004){#tca13527-fig-0004}

Deletion of miR‐519d‐3p overturned the suppressive effect of circ_0007385 on NSCLC cell proliferation, migration, invasion, and DDP resistance in vitro {#tca13527-sec-0024}
-------------------------------------------------------------------------------------------------------------------------------------------------------

Thereby, we speculated that circ_0007385 modulate the malignant progression of NSCLC cells by directly regulating miR‐519d‐3p expression. The anti‐miR‐519d‐3p was used to delete miR‐519d‐3p expression in A549 and H1975 cells, and RT‐qPCR further validated this silencing efficiency (Fig [5a](#tca13527-fig-0005){ref-type="fig"}). Cell proliferation was inhibited by circ_0007385 downregulation in A549 and H1975 cells, which was abolished by the presence of anti‐miR‐519d‐3p, as described by improved cell viability (Fig [5b and c](#tca13527-fig-0005){ref-type="fig"}) and PCNA expression (Fig [5f](#tca13527-fig-0005){ref-type="fig"}). Cell migration and invasion were also restrained by circ_0007385 silencing, and then rescued by anti‐miR‐519d‐3p transfection, as evidenced by higher numbers of transwell migratory and invasive cells (Fig [5d and e](#tca13527-fig-0005){ref-type="fig"}), increased N‐cad expression, and decreased E‐cad level (Fig [5f](#tca13527-fig-0005){ref-type="fig"}). On the contrary, the promotion of circ_0007385 knockdown on DDP sensitivity was abrogated by the deletion of miR‐519d‐3p, as depicted by elevated IC50 (Fig [5g](#tca13527-fig-0005){ref-type="fig"}), and descended apoptosis rate (Fig [5h](#tca13527-fig-0005){ref-type="fig"}) and caspase‐3 activity (Fig [5i and j](#tca13527-fig-0005){ref-type="fig"}). Collectively, these outcomes showed that miR‐519d‐3p inhibition could overturn the suppressive effect of circ_0007385 knockdown on cell proliferation, migration, invasion, and DDP resistance in A549 and H1975 cells, suggesting the role of circ_0007385 in the malignant progression of NSCLC cells by sponging miR‐519d‐3p.

![The contribution of miR‐519d‐3p to the effect of circ_0007385 knockdown in NSCLC cells in vitro. (**a**) RT‐qPCR measured miR‐519d‐3p level in A549 and H1975 cells transfected with miR‐519d‐3p inhibitor (anti‐miR‐519d‐3p) or its control miR‐NC inhibitor (anti‐NC) (![](TCA-11-2196-g009.jpg "image")) anti‐NC, (![](TCA-11-2196-g010.jpg "image")) anti‐miR‐519d‐3p. (**b**--**j**) A549 and H1975 cells were transfected with sh‐circ or sh‐NC, and cotransfected with sh‐circ and anti‐miR‐519d‐3p, or sh‐circ and anti‐NC. (**b** and **c**) CCK‐8 assessed OD450 nm value on 24, 48 and 72 hours (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ, (![](TCA-11-2196-g015.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g016.jpg "image")) sh‐circ+anti‐miR‐519d‐3p; (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ, (![](TCA-11-2196-g015.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g016.jpg "image")) sh‐circ+anti‐miR‐519d‐3p. (**d** and **e**) Transwell assays determined the numbers of migratory and invasive cells (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p. (**f**) Western blotting detected protein expression of the PCNA, E‐cad and N‐cad (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p. (**g**--**j**) A549 and H1975 cells transfected with sh‐circ or sh‐NC were treated with DDP for 48 hours. (**g**) CCK‐8 measured IC50 of DDP after treatment of 0, 2.5, 5, 10, 20, 40, and 80 μM of DDP (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p. (**h**) FCM examined apoptosis rate (%) (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p and (**i** and **j**) caspase‐3 activity after treatment of 10 μM of DDP (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+anti‐NC, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+anti‐miR‐519d‐3p. \*\**P* \< 0.01.](TCA-11-2196-g005){#tca13527-fig-0005}

HMGB1 was a target gene of miR‐519d‐3p in NSCLC cells {#tca13527-sec-0025}
-----------------------------------------------------

To investigate the downstream functional gene of miR‐519d‐3p, we employed the StarBase database to predict the binding site between miR‐519d‐3p and HMGB1 (Fig [6a](#tca13527-fig-0006){ref-type="fig"}). Dual‐luciferase reporter assay determined a significant loss of luciferase activity of HMGB1 3\'UTR WT in A549 and H1975 cells transfected with miR‐519d‐3p mimic (Fig [6b and c](#tca13527-fig-0006){ref-type="fig"}). In NSCLC, expression of HMGB1 protein was upregulated in three tumor tissues (Fig [6d](#tca13527-fig-0006){ref-type="fig"}) and two cell lines (Fig [6e](#tca13527-fig-0006){ref-type="fig"}), paralleled with that in paired normal tissues and 16HBE cells, respectively. As showed, miR‐519d‐3p mimic transfection downregulated, whereas anti‐miR‐519d‐3p transfection upregulated HMGB1 expression in A549 and H1975 cells (Fig [6g and h](#tca13527-fig-0006){ref-type="fig"}). Incidentally, the transfection efficiency was determined by RT‐qPCR (Figs [5a](#tca13527-fig-0005){ref-type="fig"} and [6f](#tca13527-fig-0006){ref-type="fig"}). Furthermore, sh‐circ transfection caused inhibition on HMGB1 expression, which was attenuated by miR‐519d‐3p deletion (Fig [6i and j](#tca13527-fig-0006){ref-type="fig"}). These data suggested that circ_0007385 could affect HMGB1 via sponging miR‐519d‐3p in NSCLC cells. Thus, we wondered the influence of HMGB1 restoration on the suppressive role of circ_0007385 knockdown in NSCLC cell malignancy. The HMGB1 restoration was mediated by overexpression vector transfection in A549 and H1975 cells (Fig [7a](#tca13527-fig-0007){ref-type="fig"}), and then blocked the inhibition of circ_0007385 knockdown on cell viability (Fig [7b and c](#tca13527-fig-0007){ref-type="fig"}), transwell migration and invasion (Fig [7d and e](#tca13527-fig-0007){ref-type="fig"}), PCNA and N‐cad expression (Fig [7f](#tca13527-fig-0007){ref-type="fig"}), as well as abrogated E‐cad expression promotion (Fig [7f](#tca13527-fig-0007){ref-type="fig"}). In addition, the suppression of circ_0007385 knockdown on DDP resistance was also counteracted with the administration of HMGB1 overexpression vector, as manifested by recovered IC50 (Fig [7g](#tca13527-fig-0007){ref-type="fig"}), and declined apoptosis rate (Fig [7h](#tca13527-fig-0007){ref-type="fig"}) and caspase‐3 activity (Fig [7i and j](#tca13527-fig-0007){ref-type="fig"}). These results suggested that circ_0007385 silencing suppressed malignant behaviors and DDP resistance of NSCLC cells in vitro by downregulating HMGB1 via miR‐519d‐3p.

![The target relationship between miR‐519d‐3p and HMGB1. (**a**) The StarBase algorithms showed the complementary binding sequence of miR‐519d‐3p on the wild‐type of HMGB1 3\'UTR (HMGB1 3\'UTR WT). The mutant type of HMGB1 3\'UTR (HMGB1 3\'UTR MUT) was constructed. 3\'UTR, 3\' untranslated region. (**b** and **c**) Dual‐luciferase reporter assay evaluated relative luciferase activity of HMGB1 3\'UTR WT/MUT in A549 and H1975 cells transfected with miR‐519d‐3p or miR‐NC (![](TCA-11-2196-g009.jpg "image")) miR‐NC, (![](TCA-11-2196-g010.jpg "image")) miR‐519d‐3p; () miR‐NC, ()miR‐519d‐3p. (**d** and **e**) Western blotting confirmed the expression of HMGB1 protein in (**d**) three paired tissues (Normal and Tumor groups), and (**e**) 16HBE, A549 and H1975 cells. (**f**) RT‐qPCR detected miR‐519d‐3p expression in A549 and H1975 cells transfected with miR‐519d‐3p or miR‐NC (![](TCA-11-2196-g009.jpg "image")) miR‐NC, (![](TCA-11-2196-g010.jpg "image")) miR‐519d‐3p. (**g** and **h**) Western blotting examined HMGB1 protein expression in A549 and H1975 cells transfected with anti‐NC, anti‐miR‐519d‐3p, miR‐NC, or miR‐519d‐3p. (**i** and **j**) Western blotting examined HMGB1 protein expression in A549 and H1975 cells transfected with sh‐NC or sh‐circ, and cotransfected with sh‐circ and anti‐NC or anti‐miR‐519d‐3p. \*\**P* \< 0.01.](TCA-11-2196-g006){#tca13527-fig-0006}

![The contribution of HMGB1 on the effect of circ_0007385 knockdown in NSCLC cells in vitro. (**a**) Western blotting measured HMGB1 protein level in A549 and H1975 cells transfected with HMGB1 overexpression vector (pEGFP‐C1‐HMGB1, HMGB1) or its control vector (vector) () vector, () HMGB1. (**b**--**j**) A549 and H1975 cells were transfected with sh‐circ or sh‐NC, and cotransfected with sh‐circ and either HMGB1 or vector. (**b** and **c**) CCK‐8 assessed OD450 nm value on 24, 48 and 72 hours (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ, (![](TCA-11-2196-g015.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g016.jpg "image")) sh‐circ+HMGB1; (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ, (![](TCA-11-2196-g015.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g016.jpg "image")) sh‐circ+HMGB1. (**d** and **e**) Transwell assay determined the numbers of migratory and invasive cells (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1. (**f**) Western blotting detected protein expression of the PCNA, E‐cad and N‐cad (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1. (**g**--**j**) Transfected A549 and H1975 cells were treated with DDP for 48 hours. (**g**) CCK‐8 measured IC50 of DDP after treatment of 0, 2.5, 5, 10, 20, 40, and 80 μM of DDP (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1. (**h**) FCM examined apoptosis rate (%) (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1 and (**i** and **j**) caspase‐3 activity after treatment of 10 μM of DDP (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1; (![](TCA-11-2196-g009.jpg "image")) sh‐NC, (![](TCA-11-2196-g010.jpg "image")) sh‐circ, (![](TCA-11-2196-g013.jpg "image")) sh‐circ+vector, (![](TCA-11-2196-g014.jpg "image")) sh‐circ+HMGB1. \*\**P* \< 0.01.](TCA-11-2196-g007){#tca13527-fig-0007}

Silenced circ_0007385 retarded the tumor growth of NSCLC cells in vivo {#tca13527-sec-0026}
----------------------------------------------------------------------

To explore the impact of circ_0007385/miR‐519d‐3p/HMGB1 axis on the tumorigenesis of NSCLC cells in vivo, A549 cells were transfected with sh‐circ or sh‐NC, and then subcutaneously injected into the right flanks of nude mice (*n* = 5). Tumor growth of A549 cells in mice was dramatically retarded in the sh‐circ group compared with the sh‐NC group, as indicated by decreased tumor volume (Fig [8a](#tca13527-fig-0008){ref-type="fig"}) and tumor weight (Fig [8b](#tca13527-fig-0008){ref-type="fig"}). Molecularly, sh‐circ transfection led to circ_0007385 knockdown in the tissues from neoplasm (Fig [8c](#tca13527-fig-0008){ref-type="fig"}), accompanied with miR‐519d‐3p upregulation (Fig [8d](#tca13527-fig-0008){ref-type="fig"}) and HMGB1 protein downregulation (Fig [8e](#tca13527-fig-0008){ref-type="fig"}). These data demonstrated that circ_0007385 knockdown retarded tumor growth of NSCLC cells in vivo partially through synergistically regulating miR‐519d‐3p and HMGB1.

![The effect of circ_0007385 knockdown on tumor growth in vivo. A549 cells were transfected with sh‐circ or sh‐NC, and then subcutaneously injected into the right flanks of nude mice (*n* = 5). (**a**) Tumor volume was measured every seven days after cell transplantation (![](TCA-11-2196-g011.jpg "image")) sh‐NC, (![](TCA-11-2196-g012.jpg "image")) sh‐circ. (**b**) Tumor weight was examined on day 28. (**c** and **d**) RT‐qPCR detected circ_0007385 and miR‐519d‐3p expression levels in tissues from neoplasm. (**e**) Western blotting evaluated HMGB1 protein expression level in tissues from neoplasm.](TCA-11-2196-g008){#tca13527-fig-0008}

Discussion {#tca13527-sec-0027}
==========

circRNAs have been found to be differentially expressed in NSCLC patients. For example, the expression profile of circRNAs in peripheral whole blood of patients (*n* = 5) with lung adenocarcinoma (LUAD, a main subtype of NSCLC) has been identified.[^24^](#tca13527-bib-0024){ref-type="ref"} Therefore, circRNAs in blood have already been considered as potent biomarkers for the prognosis and therapeutic response of NSCLC.[^25^](#tca13527-bib-0025){ref-type="ref"} CircRNAs microarray analysis has identified many differently expressed circRNAs in NSCLC tumor tissues (*n* = 3) paralleled with matched nontumor tissues.[^19^](#tca13527-bib-0019){ref-type="ref"}, [^26^](#tca13527-bib-0026){ref-type="ref"} Moreover, RNA sequencing analyses profiled circRNA expression patterns in 10 pairs of LUAD and lung squamous cell carcinoma (LUSC), two subtypes of NSCLC, and two circRNAs (hsa_circ_0001073 and hsa_circ_0001495) have been proposed to distinguish LUAD and LUSC.[^27^](#tca13527-bib-0027){ref-type="ref"} Functionally, multiple oncogenic circRNAs, such as circRNA ARHGAP10, circNT5E, and circ‐ZKSCAN1, have been certified to contribute to NSCLC cell proliferation and metastasis in vitro and in vivo;[^26^](#tca13527-bib-0026){ref-type="ref"}, [^28^](#tca13527-bib-0028){ref-type="ref"}, [^29^](#tca13527-bib-0029){ref-type="ref"} DDP resistance in NSCLC cells has also been declared to be affected by several circRNAs, including circ‐SMARCA5, circ_0076305 and circ_0001946.[^30^](#tca13527-bib-0030){ref-type="ref"}, [^31^](#tca13527-bib-0031){ref-type="ref"}, [^32^](#tca13527-bib-0032){ref-type="ref"}

According to the findings of Jiang *et al*.,[^19^](#tca13527-bib-0019){ref-type="ref"} circ_0007385 might function as an oncogene in NSCLC carcinogenesis, and miR‐181 was a target of circ_0007385. Here, we reported the upregulation of circ_0007385 in NSCLC tissues and cell lines, and discovered a suppressive effect of circ_0007385 deletion on cell proliferation, migration and invasion in A549 and H1975 cells, and tumor growth in vivo. These findings were in accordance with a previous study in A549 and H1299 cells.[^19^](#tca13527-bib-0019){ref-type="ref"} Similarly, we predicted and confirmed miR‐519d‐3p as a novel target of circ_0007385; notably, HMGB1 as a downstream functional gene of circ_0007385/miR‐519d‐3p axis was further validated. Furthermore, we noticed that circ_0007385 knockdown suppressed DDP resistance of NSCLC cells in vitro, as evidenced by the lowered IC50 of DDP, and elevated DDP‐induced apoptosis rate and caspase‐3 activity in A549 and H1975 cells. Clinically, we discovered that low expression of circ_0007385 might predict a relative better overall survival in NSCLC patients, hinting a potential biomarker of circ_0007385 for the prognosis of NSCLC tumors. Therefore, we established a circ_0007385/miR‐519d‐3p/HMGB1 pathway underlying the oncogenic role of circ_0007385 in NSCLC.

Emerging evidences on the tumor suppressive role of miR‐519d‐3p have been reported in cell progression in different cancers, such as colorectal cancer, oral squamous cell carcinoma, and pancreatic cancer.[^33^](#tca13527-bib-0033){ref-type="ref"}, [^34^](#tca13527-bib-0034){ref-type="ref"}, [^35^](#tca13527-bib-0035){ref-type="ref"} Unfortunately, there has been little research on its role in lung cancer cells to date, except for the association with immune infiltration, cell proliferation and invasion in LUAD.[^36^](#tca13527-bib-0036){ref-type="ref"}, [^37^](#tca13527-bib-0037){ref-type="ref"} Nevertheless, miR‐519d‐3p expression has been reported to have no significant correlation to clinical characteristics (age, gender, smoking history, and tumor staging).[^17^](#tca13527-bib-0017){ref-type="ref"} Herewith, we confirmed the downregulation of miR‐519d‐3p in NSCLC tissues and cells, which is consistent with other publications.[^18^](#tca13527-bib-0018){ref-type="ref"}, [^36^](#tca13527-bib-0036){ref-type="ref"}, [^37^](#tca13527-bib-0037){ref-type="ref"} In addition, miR‐519d‐3p expression has been found to be correlated to circ_0007385, and downregulation of miR‐519d‐3p could reverse circ_0007385 silence‐mediated inhibition on cell proliferation, migration, invasion, and DDP resistance in A549 and H1975 cells. Incidentally, miR‐519d‐3p had previously demonstrated as inhibitory factor of DDP resistance in colorectal, breast and ovarian cancers.[^38^](#tca13527-bib-0038){ref-type="ref"}, [^39^](#tca13527-bib-0039){ref-type="ref"}, [^40^](#tca13527-bib-0040){ref-type="ref"} Taking these findings together, we concluded that there is a close association among miR‐519d‐3p, tumor cell progression and DDP resistance in cancers. More importantly, we validated circ_0007385 as a novel ceRNA for miR‐519d‐3p, and HMGB1 as a new downstream target of miR‐519d‐3p.

HMGB1 had been assessed as one diagnostic and prognostic biomarker in NSCLC, especially in LUAD.[^41^](#tca13527-bib-0041){ref-type="ref"} Expression of HMGB1 has been reported to be highly expressed in NSCLC tissues, sera and pleural effusions from NSCLC patients.[^42^](#tca13527-bib-0042){ref-type="ref"}, [^43^](#tca13527-bib-0043){ref-type="ref"} Here, we observed upregulation of HMGB1 in three NSCLC tissues and two cell lines (A549 and H1975). Functionally and mechanically, HMGB1 has been previously described to be a downstream target of miRNAs in NSCLC cell proliferation, migration and invasion, such as miR‐520a‐3p, miR‐449a and miR‐200c.[^44^](#tca13527-bib-0044){ref-type="ref"}, [^45^](#tca13527-bib-0045){ref-type="ref"}, [^46^](#tca13527-bib-0046){ref-type="ref"} Here, we clarified a pro‐proliferation effect of HMGB1 in A549 and H1975 cells with circ_0007385 knockdown. Molecularly, HMGB1 was targeted by miR‐519d‐3p, and circ_0007385 could regulate HMGB1 expression by sponging miR‐519d‐3p. On the other hand, HMGB1 could sensitize NSCLC cells to chemotherapeutic drugs including DDP.[^47^](#tca13527-bib-0047){ref-type="ref"} Interfering HMGB1 increased DDP sensitivity in A549/DDP cells by inducing apoptosis, and inhibiting cell viability and autophagy;^47,\ 48^ on the contrary, restoring HMGB1 reduced DDP sensitivity by facilitating cell proliferation, migration and invasion in A549 and H1299 cells via SNHG14/miR‐34a/HMGB1 axis.[^49^](#tca13527-bib-0049){ref-type="ref"} Here, we determined that HMGB1 upregulation could contribute to DDP resistance in circ_0007385‐silenced A549 and H1975 cells, as evidenced by an increase in cell viability and decrease of DDP‐induced apoptosis rate and caspase‐3 activity.

However, the contribution of circ_0007385/miR‐519d‐3p/HMGB1 to many other important cell behaviors such as cell‐cycle regulation, epithelial‐mesenchymal transition and autophagy has not been discussed in our study. .[^12^](#tca13527-bib-0012){ref-type="ref"}, [^48^](#tca13527-bib-0048){ref-type="ref"} However, this study may have provided first‐hand evidence on the role of circ_0007385 in DDP resistance in NSCLC cells, and suggested a novel circ_0007385/miR‐519d‐3p/HMGB1 regulatory pathway in the malignant development of NSCLC.

In conclusion, this study demonstrated that circ_0007385 was upregulated in NSCLC tissues and cells, and its high expression could predict a shorter five‐year overall survival. The silencing of circ_0007385 could suppress cell proliferation, migration, invasion, and DDP resistance in NSCLC cells in vitro through regulating miR‐519d‐3p/HMGB1 axis, accompanied with tumor growth inhibition in vivo. These outcomes might enhance our understanding of molecular mechanisms underlying the malignant progression of NSCLC.
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